APT Medical

APT Medical Assets per Share

The Total Assets per Share of APT Medical (688617.SS) as of Nov 3, 2026 is 25.91 CNY. In the previous year, Total Assets per Share was 21.13 CNY — a change of 22.63% (higher).

Assets per Share

25.91CNY

YoY

22.63%

Last updated:

Total Assets per Share of APT Medical is 2025 25.91 CNY. Total Assets per Share of APT Medical was 2024 21.13 CNY. It decreases by 22.63% higher compared to the previous year.

The APT Medical Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
2.31 CNY
Jan 1, 2019
3.98 CNY
Jan 1, 2020
4.17 CNY
Jan 1, 2021
14.27 CNY
Jan 1, 2022
15.78 CNY
Jan 1, 2023
18.24 CNY
Jan 1, 2024
21.13 CNY
Jan 1, 2025
25.91 CNY
The APT Medical Assets per Share history
YEARAssets per ShareYoY
25.91CNY+22.63%
21.13CNY+15.85%
18.24CNY+15.59%
15.78CNY+10.58%
14.27CNY+241.95%
4.17CNY+4.93%
3.98CNY+72.19%
2.31CNY+28.91%
1.79CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

APT Medical Stock analysis

What does APT Medical do? APT Medical Inc generates revenue through the research, development, production, and sale of electrophysiology, coronary access, and peripheral vascular intervention medical devices. The company offers electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and multichannel electrophysiological systems under its electrophysiology product line. Its coronary access segment includes guide wires, micro catheters, balloons, contrast guide wires, and catheters. Peripheral vascular intervention products address peripheral vascular diseases and are sold domestically and internationally. The firm also engages in original equipment manufacturer (OEM) business, producing products for other brands. Domestic and overseas markets are the primary sales channels for all product segments. The company's electrophysiology products target healthcare providers specializing in cardiac procedures, while coronary access devices serve interventional cardiologists and vascular surgeons. Peripheral vascular intervention solutions are marketed to hospitals and clinics treating vascular conditions. OEM partnerships allow APT Medical to supply components to other medical device manufacturers without direct branding. These segments collectively drive revenue through direct sales to healthcare institutions and international distributors. APT Medical Inc's product portfolio includes electrophysiological systems and coronary access tools that cater to specific medical specialties. The firm's peripheral vascular intervention products are designed for treating conditions like peripheral artery disease. OEM business contributes to revenue by manufacturing components for other companies' branded products. Domestic market sales and overseas distribution networks form the core of the company's commercial strategy, with no mention of specific customer names or financial figures beyond the employee count. APT Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about APT Medical stock

Total Assets per Share of APT Medical is 25.91 CNY in 2025.

Total Assets per Share of APT Medical changed from 21.13 CNY to 25.91 CNY, representing a 22.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share APT Medical since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — APT Medical

All Key Metrics — APT Medical